Revolutionary Cancer Vaccine Targets Any Solid Tumors
7 Articles
7 Articles
Revolutionary Cancer Vaccine Targets Any Solid Tumors
The method triggers immune responses that inhibit melanoma, triple-negative breast cancer, lung carcinoma, and ovarian cancer. Cancer treatment vaccines have been in development since 2010, when the first was approved for prostate cancer, followed by another in 2015 for melanoma. While many therapeutic (rather than preventive) cancer vaccines have been researched since then, none have [...]
Revolutionary Cancer Vaccine Paves Way for Potent Immune Defense Against Tumors
A groundbreaking cancer vaccine from Tufts University enhances the immune system’s ability to target and annihilate cancer cells. The vaccine employs a lysate of protein fragments from solid tumors, allowing it to target various cancers, including melanoma and breast cancer. Innovative use of a ubiquitin tag in the vaccine aids in displaying tumor proteins to the immune system, prompting a robust response. Animal models show effective resistance…
Coverage Details
Bias Distribution
- 100% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage